{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-003061","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2022-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.907358+00:00","generated_at":"2026-06-27T16:33:41.980663+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Hoth Therapeutics director Vadim Mats resigns from Board effective Jan 31, 2022","bullets":["Director Vadim Mats informed the Company he will resign from the Board and its compensation and nominating/corporate governance committees.","Resignation effective January 31, 2022; not due to any disagreement with the Company's operations, policies, management, or Board.","No replacement has been announced; Board size will decrease by one member."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-003061","json":"https://secwatch.observer/filing/0001213900-22-003061.json","markdown":"https://secwatch.observer/filing/0001213900-22-003061.md","text":"https://secwatch.observer/filing/0001213900-22-003061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/0001213900-22-003061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/ea154246-8k_hoththerap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:33:41.980663+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1320e3170b","claim":"Vadim Mats departed as Director at Hoth Therapeutics, Inc..","evidence_excerpt":"On January 19, 2022, Vadim Mats informed Hoth Therapeutics, Inc. (the “Company”) that he will be resigning from the Company’s Board of Directors (the “Board”) as well as the Company’s compensation committee and nominating and corporate governance committee effective as of January 31, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/0001213900-22-003061-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}